Boryung Pharm (003850) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.060x

Based on the latest financial reports, Boryung Pharm (003850) has a cash flow conversion efficiency ratio of 0.060x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩48.95 Billion ≈ $33.18 Million USD) by net assets (₩818.35 Billion ≈ $554.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 003850 net asset quality score to measure how much of total assets are equity-financed.

Boryung Pharm - Cash Flow Conversion Efficiency Trend (2009–2024)

This chart illustrates how Boryung Pharm's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 003850 cash flow quality score to evaluate the quality of earnings relative to operating cash generation.

Boryung Pharm Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Boryung Pharm ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Jilin University Zhengyuan Info Tech SHE:003029	-0.019x
Shanghai Yanhua Smartech Group SHE:002178	-0.003x
TaiMed Biologics TWO:4147	0.007x
Eastern & Oriental Bhd KLSE:3417	-0.010x
Haixia Envrnmnt SHG:603817	0.015x
Univanich Palm Oil Public Company Limited BK:UVAN	0.184x
Tengda Construction Group Co Ltd SHG:600512	-0.002x
Jiangxi Naipu Mining Machinery SHE:300818	-0.022x

Annual Cash Flow Conversion Efficiency for Boryung Pharm (2009–2024)

The table below shows the annual cash flow conversion efficiency of Boryung Pharm from 2009 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of Boryung Pharm.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩784.50 Billion ≈ $531.65 Million	₩80.56 Billion ≈ $54.59 Million	0.103x	+33.57%
2023-12-31	₩549.25 Billion ≈ $372.22 Million	₩42.22 Billion ≈ $28.61 Million	0.077x	+42.73%
2022-12-31	₩516.42 Billion ≈ $349.97 Million	₩27.81 Billion ≈ $18.85 Million	0.054x	-57.54%
2021-12-31	₩474.31 Billion ≈ $321.44 Million	₩60.17 Billion ≈ $40.77 Million	0.127x	-3.52%
2020-12-31	₩340.29 Billion ≈ $230.61 Million	₩44.74 Billion ≈ $30.32 Million	0.131x	-20.84%
2019-12-31	₩282.95 Billion ≈ $191.75 Million	₩47.00 Billion ≈ $31.85 Million	0.166x	+9.32%
2018-12-31	₩256.10 Billion ≈ $173.56 Million	₩38.91 Billion ≈ $26.37 Million	0.152x	+254.12%
2017-12-31	₩249.65 Billion ≈ $169.19 Million	₩-24.61 Billion ≈ $-16.68 Million	-0.099x	-305.69%
2016-12-31	₩195.35 Billion ≈ $132.39 Million	₩9.36 Billion ≈ $6.35 Million	0.048x	-61.98%
2012-12-31	₩145.79 Billion ≈ $98.80 Million	₩18.38 Billion ≈ $12.46 Million	0.126x	+89.34%
2011-12-31	₩137.97 Billion ≈ $93.50 Million	₩9.19 Billion ≈ $6.23 Million	0.067x	-62.35%
2010-12-31	₩136.41 Billion ≈ $92.44 Million	₩24.12 Billion ≈ $16.35 Million	0.177x	+510.22%
2009-12-31	₩124.01 Billion ≈ $84.04 Million	₩3.59 Billion ≈ $2.44 Million	0.029x	--

About Boryung Pharm

KO:003850 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$468.89 Million

₩691.90 Billion KRW

Market Cap Rank

#12361 Global

#326 in Korea

Share Price

₩8190.00

Change (1 day)

+4.33%

52-Week Range

₩7570.00 - ₩10680.00

All Time High

₩21257.60